| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418954C 3h-quinazolin-4-one derivatives |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/17/2008 | CN100418950C Process for the manufacture of quinoline derivatives |
| 09/17/2008 | CN100418948C Hydroxypyridine cgrp receptor antagonists |
| 09/17/2008 | CN100418944C Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 09/17/2008 | CN100418941C Method for pruification of alpha-hydroxy acid on industrial scale |
| 09/17/2008 | CN100418578C Medication composition of plant estrogens for treating colpitis |
| 09/17/2008 | CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/17/2008 | CN100418575C Compound calcium preparation for astronaut |
| 09/17/2008 | CN100418548C Medicinal composition and use thereof |
| 09/17/2008 | CN100418539C Liquid polysaccharide, glycan nano-selenium, prepn. method and storage method thereof |
| 09/17/2008 | CN100418538C Compound nutrient for raising body's hypoxia tolerance |
| 09/17/2008 | CN100418537C Amphotericin B slow-releasing microsphere, and its prepn. method |
| 09/17/2008 | CN100418536C Ophthalmic pharmaceutical composition for resisting fungus |
| 09/17/2008 | CN100418535C Aescin medicine composition and its prepn process and use |
| 09/17/2008 | CN100418534C Traditional Chinese medicine active part compound preparation for curing cardiac and cerebral vascular diseases and its preparing method |
| 09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 09/17/2008 | CN100418532C Use of NF-kB inhibitor for treating several diseases |
| 09/17/2008 | CN100418531C Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 09/17/2008 | CN100418530C Ketoconazole eye drops and fabricating method thereof |
| 09/17/2008 | CN100418529C Application of Nepider in preparing medicine to accelerate ejection of calculus for urinary system |
| 09/17/2008 | CN100418528C Heat-sensitive gel containing matrine alkaloid and its preparing method |
| 09/17/2008 | CN100418527C Improved pharmaceutical formulations |
| 09/17/2008 | CN100418526C Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 09/17/2008 | CN100418525C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 09/17/2008 | CN100418524C Stable medicine composition of artemisinin or its derivative |
| 09/17/2008 | CN100418523C Prepn process of double-layer catechin microcapsule |
| 09/17/2008 | CN100418522C High-dose hydroxy safflower yellow A or its medically-acceptable salt application for preparing medicine for cerebral apoplexy induced from being ischemic |
| 09/17/2008 | CN100418521C Gusuibu extracts for trvating osteoporosis and method for extracting same |
| 09/17/2008 | CN100418520C Apoferritin ¿Cplatinum anticancer drug composition and preparation method thereof |
| 09/17/2008 | CN100418518C Injectable diacetylamino acetic ethylenediamine prepn. preparing method and quality-control tech. therefor |
| 09/17/2008 | CN100418517C Alpha-aminoamide derivatives useful as antimigraine agents |
| 09/17/2008 | CN100418506C Anti-germ attachment composition |
| 09/17/2008 | CN100418430C Biological health tea |
| 09/16/2008 | US7425651 Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof |
| 09/16/2008 | US7425649 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 09/16/2008 | US7425644 Measuring level of compactin C in samples; selecting a compactin batch that comprises little compactin C; synthesizing pravastin having little pravastin C by hydroxylation of fermentation of compactin |
| 09/16/2008 | US7425642 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
| 09/16/2008 | US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 09/16/2008 | US7425640 e.g. 5-(2-benzyloxy-cyclohexylcarbamoyl)-1-[(2-benzyloxy-cyclohexylcarbamoyl)-methyl]-1H-pyrazole-3-carboxylic acid ethyl ester; inhibiting hepatitis C virus (HCV) RNA-dependent RNA polymerase; HIV infection, AIDS; with additional antiviral agent as ribavirin and alpha -interferon or pegylated interferon |
| 09/16/2008 | US7425639 Process |
| 09/16/2008 | US7425638 Cis-imidazolines |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425636 2-amino-5phenyl-(1,3,4)thiodiazoline derivatives; antitumor, anticarcinogenic agent; transcription factor STAT6 and integrin antagonist; breast, gastric, ovarian, colon, lung, brain, hematological, urinary or genital, bladder, prostatic, renal, pancreatic, uterine cancers, skin, hepatic carcinoma |
| 09/16/2008 | US7425635 Use in reducing unwanted side effects of chemo- or radiotherapy of cancer, improving cardiovascular function, preventing mutagenesis, preventing initiation or progression of cancer, reducing toxic consequences of radiation exposure |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425627 Methods of synthesizing olanzapine |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425617 Antibodies to the cell cycle regulatory protein p16 |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425580 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands |
| 09/16/2008 | US7425579 Methods for inhibiting activity of polyamine transporters |
| 09/16/2008 | US7425578 Immunoregulatory compounds and derivatives and methods of treating diseases therewith |
| 09/16/2008 | US7425577 Lipase-colipase inhibitor |
| 09/16/2008 | US7425576 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis |
| 09/16/2008 | US7425575 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 09/16/2008 | US7425574 Benzofuran oxyethylamines as antidepressants and anxiolytics |
| 09/16/2008 | US7425573 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration |
| 09/16/2008 | US7425572 and elevated intraocular pressure; e.g. 2-(7,8-Dihydro-[1,4]dioxino[2,3-g]indazol-1-yl)-1-methyl-ethylamine; serotonin 5-HT2 receptor agonists; chemical stability, sustained release |
| 09/16/2008 | US7425571 synergistic admnistration of a weight-loss promoting anticonvulsant and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 09/16/2008 | US7425570 Pyridoxine and pyridoxal analogues: new uses |
| 09/16/2008 | US7425569 Use treating endometriosis, uterine fibroids (leiomyomata), menorrhagia, adenomyosis, dysmenorrhoea, or chronic pelvic pain syndrome; 4-(3-cyclopropyl-1-methanesulfonylmethyl-5-methyl-1H-pyrazol-4-yloxy)-2,6-dimethyl-benzonitrile for example; progesterone receptor antagonists |
| 09/16/2008 | US7425568 Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425565 Use of benzothiopenes to treat and prevent prostate cancer |
| 09/16/2008 | US7425564 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same |
| 09/16/2008 | US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 09/16/2008 | US7425562 Inhibitors of cruzipain and other cysteine proteases |
| 09/16/2008 | US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | US7425559 Medicine containing pyrimidine derivative |
| 09/16/2008 | US7425558 Serotonergic agents for treating sexual dysfunction |
| 09/16/2008 | US7425557 Inhibitors of glycogen synthase kinase 3 |
| 09/16/2008 | US7425556 Compounds and uses thereof |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | US7425553 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 09/16/2008 | US7425552 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction |
| 09/16/2008 | US7425551 N [(S)-5-(2-hydroxy-ethyl)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-2-methyl-N '-(2,2,3,3,3-pentafluoro-propyl)-malonamide; Alzheimer's disease; cancers; gamma -secretase inhibitors; good solubility, potentiation and selectivity |
| 09/16/2008 | US7425550 Lactam glycogen phosphorylase inhibitors and method of use |
| 09/16/2008 | US7425549 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 09/16/2008 | US7425548 Materials and methods for immune system stimulation |
| 09/16/2008 | US7425547 Nucleoside derivatives for treating hepatitis C virus infection |
| 09/16/2008 | US7425546 Adjusting treatment by determining the level of 6-thioguanine present from red blood cells in a subject receiving azathioprine or 6-mercaptopurine therapy; there is a higher likelihood of response when said determined level of 6-thioguanine is 230 - 450 pmol per 8x108 red blood cells; Crohn's disease |
| 09/16/2008 | US7425545 Antisense oligonucleotide for use in controlling c-reactive protein expression and treatment and prevention of adipocyte differentiation, obesity, hyperlipidemia, atherosclerosis and hypertension |
| 09/16/2008 | US7425544 Modulation of eIF4E expression |
| 09/16/2008 | US7425543 Microencapsulated materials and method of making same |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425451 Sequestering proteins, peptides; determination concentration in mixture; analyzing by mass spectroscopy |
| 09/16/2008 | US7425438 Vector for anti-HPV vaccine and transformed microorganism by the vector |
| 09/16/2008 | US7425356 Liquid crystalline polymers mixture:, display, optics, diagnosis |
| 09/16/2008 | US7425343 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 09/16/2008 | US7425340 a mixture of antispasmodic agents and carriers comprising urea compounds for intensifying permeability through the skin or mucous membranes, used for treating incontinence; side effect reduction |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425323 topical emulsions, creams, lotions, gels, ointments or solutions comprising a mixture of cationic surfactants, anionic surfactants, chelate compounds, magnesium ascorbyl phosphate, vegetable oils and cucumber extracts, used for activating proteolytic enzymes on the epidermis and dermis; cosmetics |
| 09/16/2008 | US7425322 Responsive biomedical composites |
| 09/16/2008 | US7425319 Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide |
| 09/16/2008 | US7425318 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |